Literature DB >> 20836310

Aqueous leaf extract of Ocimum gratissimum potentiates activities of plasma and hepatic antioxidant enzymes in rats.

O M Ighodaro1, O A T Ebuehi.   

Abstract

BACKGROUND: Ocimum gratissimum is a vegetable plant of wide nutritional and medicinal aŕpplications in Nigeria and in some other parts of the world.
OBJECTIVE: The effect of oral administration of aqueous leaf extract of O. gratissimum on the activities of plasma and hepatic anti-oxidant enzymes in rats was investigated.
METHODS: Two different doses of aqueous leaf extract of O. gratissimum (0.2 mg/g and 0.4 mg/kg body weight) were separately administered orally daily into rats for 4 weeks. The rats were sacrificed after 30 days of administration, blood was collected and the liver excised. The liver was homogenized, while plasma and hepatic anti-oxidant enzymes, namely catalase (CAT), superoxide dismutase (SOD) and glutathione -S- transferase (GST) specific activities were assayed.
RESULTS: Results of the study showed a significant (p < 0.05) increase in the specific activity of both plasma and hepatic CAT and SOD in a dose dependent pattern. However, the effect of the leaf extract on GST specific activity was not significant (p > 0.05) as compared to the control. There were no significant changes in the plasma and liver protein concentrations in rats administered the extracts as compared to the control.
CONCLUSION: Data of the study suggest that the oral administration of the aqueous extract of O. gratissimum may impair naturally generated oxidant/toxicant activity and thereby enhance specific activities of hepatic antioxidant enzymes in rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20836310

Source DB:  PubMed          Journal:  Nig Q J Hosp Med        ISSN: 0189-2657


  1 in total

1.  Beneficial Effects of Ocimum gratissimum Aqueous Extract on Rats with CCl(4)-Induced Acute Liver Injury.

Authors:  Chun-Ching Chiu; Chih-Yang Huang; Tzy-Yen Chen; Shao-Hsuan Kao; Jer-Yuh Liu; Yi-Wen Wang; Bor-Show Tzang; Tsai-Ching Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-27       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.